Comparison of 2-dimensional and 3-dimensional 82Rb myocardial perfusion PET imaging

Journal of Nuclear Medicine

Volumn 44, Issue 8, 2003, Pages 1350-1356

  Knešaurek, Karin ^a,b   Machac, Josef ^a   Krynyckyi, Borys R ^a   Almeida, Orlandino D ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b Division of Nuclear Medicine   (United States)

Author keywords

2 Dimensional PET; 3 Dimensional PET; 82Rb; Myocardial perfusion

Indexed keywords

RUBIDIUM 82; WATER; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; RUBIDIUM;

ARTICLE; CALCULATION; CLINICAL PROTOCOL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DISEASE SIMULATION; DRUG MEGADOSE; EVALUATION; HEART; HEART LEFT VENTRICLE WALL; HEART MUSCLE PERFUSION; HUMAN; INTERMETHOD COMPARISON; LINEAR SYSTEM; LOW DRUG DOSE; PERFORMANCE; PHANTOM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; REACTION TIME; STATISTICAL SIGNIFICANCE; THORAX; THREE DIMENSIONAL IMAGING; VISUAL ANALOG SCALE; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; IMAGE QUALITY; INSTRUMENTATION; MALE; METHODOLOGY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

HEART; HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; PHANTOMS, IMAGING; RADIOPHARMACEUTICALS; RUBIDIUM RADIOISOTOPES; SENSITIVITY AND SPECIFICITY; THORAX; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0141557956     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Cherry SR, Woods RP, Hoffman EJ, Mazziota JC. Improved detection of focal cerebral blood flow changes using three-dimensional positron emission tomography. J Cereb Blood Flow Metab. 1993;13:630-638
2. 15O-water and three-dimensional positron emission tomography. J Cereb Blood Flow Metab. 1997;17:732-739
3. 15O brain activation studies, dose fractionation strategies for rCBF and signal enhancing protocols. IEEE Trans Med Imaging. 1998;17:979-985.
4. 18F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: a prospective study. J Nucl Med. 2002;43:492-499.
5. Mullani NA, Goldstein RA, Gould KL, et al. Myocardial perfusion with rubidium-82. I. Measurement of extraction fraction and flow with external detectors. J Nucl Med. 1983;24:898-906.
6. Goldstein RA, Mullani NA, Marani SK, Fisher DJ, Gould KL, O'Brien HA Jr. Myocardial perfusion with rubidium-82. II Effects of metabolic and pharmacologic interventions J Nucl Med. 1983;24:907-915.
7. Goldstein RA, Mullani NA, Wong WH, et al. Positron imaging of myocardial infarction with rubidium-82. J Nucl Med 1986;27:1824-1829.
8. Yoshida K, Mullani N, Gould KL. Coronary flow and flow reserve by PET simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia. J Nucl Med. 1996;37:1701-1712.
9. Lin JW, Robert R, Sciacca RR, Chou R-L, Laine AF, Bergmann SR. Quantification of myocardial perfusion in human subjects using Rb-82 and wavelet-based noise reduction. J Nucl Med. 2001;42:201-208.
10. Pajevic S, Daube-Witherspoon ME, Bacharach SL, Carson RE. Noise characteristics of 3D and 2D PET images. IEEE Trans Med Imaging. 1998;17:9-23.
11. DeGrado TR, Turkington TG, Williams JJ, Stearns CW, Hoffman JM, Coleman RE. Performance characteristics of a whole-body PET scanner. J Nucl Med. 1994;35:1398-1406.
12. Votaw JR, White M. Comparison of 2D and 3D cardiac Rb-82 PET studies. J Nucl Med. 2001;42:701-706.
13. Weinhard K, Eriksson L, Grootoonk S, Casey M, Pietrzyk U, Heiss WD. Performance evaluation of the positron scanner ECAT EXACT. J Comput Assist Tomogr 1992;16:804-813.
14. Lewellen TK, Kohlmyer RS, Miyaoka RS, Kaplan MS. Investigation of the performance of the General Electric ADVANCE positron emission tomograph in 3D mode. IEEE Trans Nucl Sci. 1996;NS-43:2199-2206.
15. Kinahan PE, Rogers JG. Analytic three dimensional image reconstruction using all detected events IEEE Trans Nucl Sci. 1989;NS-36:964-968.
16. Bergstrom M, Eriksson L, Bohm C, Blomqvist G, Litton J. Correction for scatter radiation in a ring detector positron camera by integral transformation of the projections. J Comput Assist Tomogr. 1983;10.845-850.
17. Stearns CW. Scatter correction method for 3-D PET using 2-D fitted gaussian functions [abstract]. J Nucl Med. 1995;36(suppl):105P.
18. Kadrmas DJ, Christian PE, Wollenweber SD, Kohlmyer SG, Stearns CW. Comparative evaluation of 2D and 3D lesion detectability on a full-ring BGO PET scanner [abstract]. J Nucl Med 2002;43(suppl):57P.
19. Lartizien C, Comtat C, Kinahan PE, et al Optimization of the injected dose based on noise equivalent count rates for 2- and 3-dimensional whole-body PET. J Nucl Med. 2002;43:1268-1278.
20. Ollinger JM Model-based scatter correction for fully 3D PET. Phys Med Biol. 1996;41:153-176
21. Knešaurek K. New developments in PET instrumentation: quo vadis PET? J Nucl Med. 2001;42:1831-1832.